JP2021512889A5 - - Google Patents

Info

Publication number
JP2021512889A5
JP2021512889A5 JP2020542437A JP2020542437A JP2021512889A5 JP 2021512889 A5 JP2021512889 A5 JP 2021512889A5 JP 2020542437 A JP2020542437 A JP 2020542437A JP 2020542437 A JP2020542437 A JP 2020542437A JP 2021512889 A5 JP2021512889 A5 JP 2021512889A5
Authority
JP
Japan
Prior art keywords
pyridine
benzodiazole
fluoro
substituted
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020542437A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512889A (ja
JP7365347B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/017529 external-priority patent/WO2019157458A1/en
Publication of JP2021512889A publication Critical patent/JP2021512889A/ja
Publication of JP2021512889A5 publication Critical patent/JP2021512889A5/ja
Application granted granted Critical
Publication of JP7365347B2 publication Critical patent/JP7365347B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020542437A 2018-02-12 2019-02-11 ソマトスタチンモジュレーターおよびその使用 Active JP7365347B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862629377P 2018-02-12 2018-02-12
US62/629,377 2018-02-12
US201862673042P 2018-05-17 2018-05-17
US62/673,042 2018-05-17
US201862724421P 2018-08-29 2018-08-29
US62/724,421 2018-08-29
PCT/US2019/017529 WO2019157458A1 (en) 2018-02-12 2019-02-11 Somatostatin modulators and uses thereof

Publications (3)

Publication Number Publication Date
JP2021512889A JP2021512889A (ja) 2021-05-20
JP2021512889A5 true JP2021512889A5 (https=) 2022-02-21
JP7365347B2 JP7365347B2 (ja) 2023-10-19

Family

ID=67548490

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020542437A Active JP7365347B2 (ja) 2018-02-12 2019-02-11 ソマトスタチンモジュレーターおよびその使用

Country Status (5)

Country Link
US (1) US11608335B2 (https=)
EP (1) EP3752498B1 (https=)
JP (1) JP7365347B2 (https=)
MA (1) MA51840A (https=)
WO (1) WO2019157458A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3596062A4 (en) 2017-03-16 2020-08-26 Crinetics Pharmaceuticals, Inc. SOMATOSTATIN MODULATORS AND THEIR USES
MA51840A (fr) 2018-02-12 2021-05-19 Crinetics Pharmaceuticals Inc Modulateurs de somatostatine et leurs utilisations
SMT202500155T1 (it) 2018-09-18 2025-05-12 Crinetics Pharmaceuticals Inc Modulatori della somatostatina e loro usi
TWI841768B (zh) 2019-08-14 2024-05-11 美商克林提克斯醫藥股份有限公司 非肽生長抑制素(somatostatin)5型受體激動劑及其用途
JP2024506716A (ja) * 2021-02-17 2024-02-14 クリネティックス ファーマシューティカルズ,インク. 高インスリン血症の処置のためのソマトスタチン受容体5型アゴニスト
JP2024506715A (ja) 2021-02-17 2024-02-14 クリネティックス ファーマシューティカルズ,インク. ソマトスタチンモジュレーターの結晶形態
IL320483A (en) * 2022-10-28 2025-06-01 Basecamp Bio Inc Somatostatin receptor 2 agonists and uses thereof
TW202440164A (zh) 2022-12-13 2024-10-16 美商克林提克斯醫藥股份有限公司 生長抑素亞型-2受體(sst2r)靶向治療劑及其用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127343A (en) 1996-05-14 2000-10-03 Novo Nordisk A/S Somatostatin agonists and antagonists
US6025372A (en) 1997-04-04 2000-02-15 Merck & Co., Inc. Somatostatin agonists
FR2802206B1 (fr) 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
US20060281764A1 (en) * 2005-06-10 2006-12-14 Gaul Michael D Aminopyrimidines as kinase modulators
AU2007309708A1 (en) * 2006-03-13 2008-05-02 Merck Sharp & Dohme Corp. Somatostatin agonists
WO2008019967A2 (en) 2006-08-15 2008-02-21 F. Hoffmann-La Roche Ag Phenyl, pyridine and quinoline derivatives
WO2009051705A1 (en) 2007-10-18 2009-04-23 Merck & Co., Inc. Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
JP2011526294A (ja) 2008-06-25 2011-10-06 エンビボ ファーマシューティカルズ インコーポレイテッド ホスホジエステラーゼ10阻害剤としての二置換フェニル化合物
GB0818241D0 (en) 2008-10-06 2008-11-12 Cancer Res Technology Compounds and their use
JP2013503846A (ja) 2009-09-01 2013-02-04 ファイザー・インク ベンズイミダゾール誘導体
AU2011256444B2 (en) 2010-05-18 2014-07-10 Merck Sharp & Dohme Corp. Spiro isoxazoline compounds as SSTR5 antagonists
GB201008290D0 (en) 2010-05-18 2010-06-30 Syngenta Ltd Chemical compounds
WO2014007228A1 (ja) * 2012-07-03 2014-01-09 小野薬品工業株式会社 ソマトスタチン受容体作動活性を有する化合物およびその医薬用途
US9643951B2 (en) 2013-09-30 2017-05-09 Ono Pharmaceutical Co., Ltd. Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof
ES2675504T3 (es) 2013-10-02 2018-07-11 Kuraray Co., Ltd. Composición de resina, lámina de múltiples capas, material de envasado y recipiente
IL264178B2 (en) * 2016-07-14 2024-05-01 Crinetics Pharmaceuticals Inc Somatostatin modulators and uses thereof
AU2018219644A1 (en) 2017-02-08 2019-08-29 Ono Pharmaceutical Co., Ltd. Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof
EP3596062A4 (en) 2017-03-16 2020-08-26 Crinetics Pharmaceuticals, Inc. SOMATOSTATIN MODULATORS AND THEIR USES
EP3658560A4 (en) 2017-07-25 2021-01-06 Crinetics Pharmaceuticals, Inc. SOMATOSTAT IN MODULATORS AND USES THEREOF
MA51840A (fr) 2018-02-12 2021-05-19 Crinetics Pharmaceuticals Inc Modulateurs de somatostatine et leurs utilisations
SMT202500155T1 (it) 2018-09-18 2025-05-12 Crinetics Pharmaceuticals Inc Modulatori della somatostatina e loro usi
TWI841768B (zh) 2019-08-14 2024-05-11 美商克林提克斯醫藥股份有限公司 非肽生長抑制素(somatostatin)5型受體激動劑及其用途

Similar Documents

Publication Publication Date Title
JP2021512889A5 (https=)
JP2019518036A5 (https=)
AU2007333992B2 (en) Compounds and compositions as inhibitors of Cannabinoid Receptor 1 activity
RU2317291C2 (ru) Производные пиримидина в качестве модуляторов рецептора инсулинподобного фактора роста 1 (igf-1), фармацевтическая композиция, способы получения (варианты) и применение
JP3930560B2 (ja) 炎症の処置のための1,2−置換イミダゾリル化合物
RU2019132212A (ru) Селективные ингибиторы hdac6
JP2018535999A5 (https=)
JP2007531752A5 (https=)
JP2018530591A5 (https=)
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
JP2019537571A5 (https=)
RU2012116207A (ru) Производные индола в качестве модуляторов crac
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
JP2015528022A5 (https=)
HRP20170506T1 (hr) Dihidropiridon p1 kao inhibitori xia faktora
JP2014511869A5 (https=)
JP2019537594A5 (https=)
JP2004531473A5 (https=)
RU2004112191A (ru) Лактамсодержащие соединения и их производные в качестве ингибиторов фактора ха
CA2714058A1 (en) 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease
RU2016108753A (ru) Ингибиторы ферментов
JP2015533157A5 (https=)
RU2003115612A (ru) Производные амидоалкилпиперидинов и амидоалкилпиперазинов, пригодные для лечения нарушений нервной системы
JP2005526815A5 (https=)
ES2197983T3 (es) Imidazoles sustituidos con heterociclo para el tratamiento de la inflamacion.